South & Central America Companion Animal Diagnostics Market Analysis and Forecast by Size, Share, Growth, Trends 2031

South & Central America Companion Animal Diagnostics Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Consumables and Instruments), Companion Animal (Dogs, Cats, Horses, and Others), Technology (Immunodiagnostics, Molecular Diagnostics, Clinical Biochemistry, Hematology, Urinalysis, and Others), Application (Clinical Pathology, Bacteriology, Parasitology, Virology, and Others), and End Users (Diagnostic and Reference Laboratories, Veterinary Hospitals and Clinics, Research Institutes, and Others)

Historic Data: 2021-2023   |   Base Year: 2024   |   Forecast Period: 2025-2031
  • Status : Published
  • Report Code : TIPRE00041944
  • Category : Life Sciences
  • No. of Pages : 142
  • Available Report Formats : pdf-format excel-format
Buy Now  
South & Central America Companion Animal Diagnostics Market Analysis and Forecast by Size, Share, Growth, Trends 2031
Report Date: Nov 2025   |   Report Code: TIPRE00041944
Buy Now

The South & Central America Companion Animal Diagnostics Market size is expected to reach US$ 797.74 Million by 2031 from US$ 443.77 Million in 2024. The market is estimated to record a CAGR of 8.8% from 2025 to 2031.

Executive Summary and South & Central America Companion Animal Diagnostics Market Analysis:

The companion animal diagnostics market in South & Central America is segmented into Brazil, Argentina, and the Rest of South & Central America. The healthcare sector in these countries is developing significantly owing to increasing investments and surging healthcare expenditure. Developments in diagnostic techniques to aid the early detection of diseases have contributed to the massive success of treating chronic diseases in pets.

In recent years, technological advancements in animal diagnostics have developed more sensitive, accurate, and specific diagnostic tests. Next-generation sequencing (NGS) technology significantly fuels the advancements in companion animal diagnostics. Also, the need for artificial intelligence (AI) and machine learning in companion animal diagnostics has increased. AI-powered algorithms are used in diagnostics to measure large volumes of data, to examine patterns, and make projections to enhance the accuracy and efficiency of diagnostic tests.

The number of pet ownerships in households has grown, with the total population of pets rising by 0.8%. Thus, the growing number of companion animals is likely to boost the region's companion animal diagnostics market growth. With the increase in pet adoption, the number of facilities for companion animals, offering transportation and other services, has also surged.

Customize This Report To Suit Your Requirement

Get FREE CUSTOMIZATION

South & Central America Companion Animal Diagnostics Market: Strategic Insights

south-and-central-america-companion-animal-diagnostics-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

South & Central America Companion Animal Diagnostics Market Segmentation Analysis:

  • By Product, the South & Central America Companion Animal Diagnostics Market is segmented into Consumables and Instruments. Consumables held the largest share of the market in 2024.
  • By Companion Animal, the South & Central America Companion Animal Diagnostics Market is segmented into Dogs, Cats, Horses, and Others. Dogs held the largest share of the market in 2024.
  • By Technology, the South & Central America Companion Animal Diagnostics Market is segmented into Immunodiagnostics, Molecular Diagnostics, Clinical Biochemistry, Hematology, Urinalysis, and Others. Immunodiagnostics held the largest share of the market in 2024.
  • By Application, the South & Central America Companion Animal Diagnostics Market is segmented into Clinical Pathology, Bacteriology, Parasitology, Virology, and Others. Clinical Pathology held the largest share of the market in 2024.
  • By End Users, the South & Central America Companion Animal Diagnostics Market is segmented into Diagnostic and Reference Laboratories, Veterinary Hospitals and Clinics, Research Institutes, and Others. Veterinary Hospitals and Clinics held the largest share of the market in 2024.

South & Central America Companion Animal Diagnostics Market Report Scope

Report Attribute Details
Market size in 2024 US$ 443.8 Million
Market Size by 2025-2031 US$ 797.7 Million
CAGR (2025 - 2031) 8.8%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Product
  • Consumables
  • Instruments
By Companion Animal
  • Dogs
  • Cats
  • Horses
  • Others
By Technology
  • Immunodiagnostics
  • Molecular Diagnostics
  • Clinical Biochemistry
  • Hematology
  • Urinalysis
  • Others
By Application
  • Clinical Pathology
  • Bacteriology
  • Parasitology
  • Virology
  • Others
Regions and Countries Covered South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Market leaders and key company profiles
  • Zoetis Inc
  • Idexx Laboratories Inc
  • Innovative Diagnostics SAS
  • Tianjin LOCMEDT Technologies Co Ltd
  • ARI Medical Technology Co Ltd
  • Demeditec Diagnostics GmbH

South & Central America Companion Animal Diagnostics Market Players Density: Understanding Its Impact on Business Dynamics

The South & Central America Companion Animal Diagnostics Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

south-and-central-america-companion-animal-diagnostics-market-cagr

South & Central America Companion Animal Diagnostics Market Outlook

The convergence of artificial intelligence (AI), data analytics, and portable diagnostic tools opens up trends for market players. From AI-powered radiograph investigation to cloud-based companion animal diagnostics platforms, the integration of technology is revolutionizing how, when, and where diagnostics can be delivered. Asia Pacific, the Middle East, Latin America, and other developing nations are noticing rapid growth in pet ownership and government investment in animal health infrastructure. These regions offer fertile ground for innovation, especially point-of-care diagnostics and mobile veterinary services. Additionally, the expanding reach of pet insurance and veterinary telemedicine enables broader access to diagnostics, turning niche segments into profitable ventures.

Integrating artificial intelligence (AI) into diagnostic platforms is a transformative trend for the companion animal diagnostics market. The development of diagnostic capacities in point-of-care settings, as demonstrated by Vetscan Imagyst, offers a unique growth avenue. Point-of-care diagnostics permit veterinarians to conduct in-clinic sediment analysis of fresh urine, diminishing the time required to obtain results. This strategy aligns with the need for rapid diagnostics, contributing to improved patient outcomes. AI in urine sediment analysis incorporates elements such as epithelial cells, red and white blood cells, crystals, casts, and bacteria, and shows a complete solution for urinalysis. In 2023, a Brazilian startup called BiDiagnostics, based in São Paulo, developed a new diagnostic test for sporotrichosis. This zoonotic fungal infection affects cats and sometimes dogs and humans. The aim is to enable faster and more accurate detection. FAPESP supports this initiative through its PIPE (Innovative Research in Small Business Program). This shows how public funding is being used to create AI and diagnostic tools for pets. The test is designed to deal with the increasing cases in domestic cats, which can lead to earlier intervention and lower the spread of the disease. It also demonstrates how digital and diagnostic innovation is impacting veterinary health in Latin America. Digital platforms also facilitate veterinary operations, from appointment scheduling and medical record control to drug medications and inventory tracking. These instruments improve the efficiency of veterinary services, reducing administrative burdens and permitting veterinarians to focus more on direct patient care. Mobile apps that offer health tracking, reminders for vaccinations and treatments, and access to educational resources are becoming increasingly popular among pet owners. These integrations of AI and digital platforms are becoming a future trend in the companion animal diagnostics market.

South & Central America Companion Animal Diagnostics Market Country Insights

By country, the South & Central America Companion Animal Diagnostics Market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil held the largest share in 2024.

Brazil is experiencing a rise in the number of pet owners, growth in awareness of animal health, and an increase in the humanization of pets. This growth is reflected in the diagnostic product market, with consumables, reagents, and kits being the largest revenue-generating segment for products, and dogs being the dominant animal type for services. Brazil represents a considerable portion of Latin America's companion animal diagnostics market. Brazil has an enormous pet population in Latin America, making it a key market for companion animal diagnostics.

The Brazil animal health market is witnessing robust growth owing to the increasing demand for veterinary healthcare services and products. The growing pet ownership in urban areas and rising awareness regarding animal health and welfare have significantly fueled the demand for preventive care, diagnostics, and treatment solutions. The livestock segment, a critical part of Brazil's economy, is also experiencing a surge in demand for health products due to the expanding export markets for meat and dairy products. Advancements in companion animal diagnostics have propelled the market's growth trajectory.

Key trends shaping the market include the rising adoption of telemedicine and digital platforms in veterinary care, allowing better access to services for pet owners and livestock farmers. The expansion of e-commerce platforms delivering animal health products has made these solutions more accessible, fostering growth among urban and rural consumers. Moreover, the focus on sustainable practices has increased demand for products that ensure animal health while supporting environmental conservation. Organizations increasingly invest in research and development to introduce products that align with these emerging consumer and industry needs. According to the Brazilian Institute of Geography and Statistics (IBGE), the veterinary services sector has experienced constant growth, with an annual increase in the number of veterinary establishments and professionals. This expansion reflects the country's commitment to improving animal health and welfare standards. The demand for animal diagnostic tools continues to grow, further contributing to the overall growth of Brazil's companion animal diagnostics market.

South & Central America Companion Animal Diagnostics Market Company Profiles

Some of the key players operating in the market include Zoetis Inc, Idexx Laboratories Inc, Innovative Diagnostics SAS, Tianjin LOCMEDT Technologies Co., Ltd., ARI Medical Technology Co., Ltd., and Demeditec Diagnostics GmbH.

These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

South & Central America Companion Animal Diagnostics Market Research Methodology

The following methodology has been followed for the collection and analysis of data presented in this report:

Secondary Research

The research process begins with comprehensive secondary research, utilizing internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

  • Company websites, annual reports, financial statements, broker analyses, and investor presentations
  • Industry trade journals and other relevant publications
  • Government documents, statistical databases, and market reports
  • News articles, press releases, and webcasts specific to companies operating in the market

Note:

All financial data included in the Company Profiles section has been standardized to US$. For companies reporting in other currencies, figures have been converted to US$ using the relevant exchange rates for the corresponding year.

Primary Research

The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis and gain valuable insights. These research interviews are designed to:

  • Validate and refine findings from secondary research
  • Enhance the expertise and market understanding of the analysis team
  • Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects

Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

  • Industry stakeholders: Vice Presidents, Business Development Managers, Market Intelligence Managers, and National Sales Managers
  • External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise
Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
Chat with us
DUNS Logo
87-673-9708
ISO Certified Logo
ISO 9001:2015
GDPR
CCPA
Page Updated: Apr 2026